2017 Apr 27
“Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses”
“To evaluate the safety and immunogenicity of H10 mRNA in humans, a randomized, double-blind, placebo-controlled, dose-escalating phase 1 trial is ongoing (Clinical Trials Identifier NCT03076385).”
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475249/
I went to the clinical trials website and no results were posted despite the study ending in 2018.
The clinical trials study was done by Moderna.
maybe someone could get the results via FOIA. probably not good.